Annovis Bio received a Notice from the NYSE indicating it is out of compliance with continued listing standards due to a market cap and equity imbalance. The company will submit a plan within 45 days to regain compliance within nine months.
Annovis Bio received a Notice from the NYSE indicating it is out of compliance with continued listing standards due to a market cap and equity imbalance. The company will submit a plan within 45 days to regain compliance within nine months.